Assignee
PRECIGEN INC
US·25 granted patents·22 pending applications·15 citations·filing 2017–2025
Top patents by PatentIndex Score
47 records- 0189US11118168B2Expression of novel cell tagsPRECIGEN INC·Filed 2018·Granted Sep 14, 2021·4 cites·5 claims
- 0289US2025027093A1Molecular switchesPRECIGEN INC·Filed 2024·Application pending·0 cites
- 0388US11319380B2MUC16 specific chimeric antigen receptors and uses thereofPRECIGEN INC·Filed 2019·Granted May 3, 2022·3 cites·11 claims
- 0486US11692194B2Modulating expression of polypeptides via new gene switch expression systemsPRECIGEN INC·Filed 2018·Granted Jul 4, 2023·2 cites·32 claims
- 0586US2024263182A1Methods and microorganisms for making 2,3-butanediol and derivatives thereof from c1 carbonsPRECIGEN INC·Filed 2024·Application pending·0 cites
- 0685US12060585B2Expression of novel cell tagsPRECIGEN INC·Filed 2021·Granted Aug 13, 2024·1 cites·15 claims
- 0783US11946054B2Modulating expression of polypeptides via new gene switch expression systemsPRECIGEN INC·Filed 2020·Granted Apr 2, 2024·1 cites·30 claims
- 0883US11116852B2Frataxin expression constructsPRECIGEN INC·Filed 2017·Granted Sep 14, 2021·2 cites·23 claims
- 0981US2025304930A1Expression of novel cell tagsPRECIGEN INC·Filed 2024·Application pending·0 cites
- 1080US2024368305A1Muc16 specific chimeric antigen receptors and uses thereofPRECIGEN INC·Filed 2024·Application pending·0 cites
- 1180US2024368637A1Methods and microorganisms for making 1,4-butanediol and derivatives thereof from c1 carbonsPRECIGEN INC·Filed 2024·Application pending·0 cites
- 1278US12091667B2Molecular switchesPRECIGEN INC·Filed 2021·Granted Sep 17, 2024·0 cites·13 claims
- 1378US2024263183A1Modulating expression of polypeptides via new gene switch expression systemsPRECIGEN INC·Filed 2024·Application pending·0 cites
- 1476US12559536B2CD33 specific chimeric antigen receptorsPRECIGEN INC·Filed 2023·Granted Feb 24, 2026·0 cites·11 claims
- 1576US11939584B2Methods and microorganisms for making 2,3-butanediol and derivatives thereof from C1 carbonsPRECIGEN INC·Filed 2021·Granted Mar 26, 2024·0 cites·15 claims
- 1676US11787848B2CD33 specific chimeric antigen receptorsPRECIGEN INC·Filed 2017·Granted Oct 17, 2023·1 cites·45 claims
- 1776US11535669B2Fusion constructs and methods of using thereofPRECIGEN INC·Filed 2019·Granted Dec 27, 2022·1 cites·15 claims
- 1875US12234261B2Hepatitis B vaccines and uses of the samePRECIGEN INC·Filed 2022·Granted Feb 25, 2025·0 cites·16 claims
- 1975US12234465B2Methods and microorganisms for the fermentation of methane to multi-carbon compoundsPRECIGEN INC·Filed 2022·Granted Feb 25, 2025·0 cites·18 claims
- 2075US11981746B2MUC16 specific chimeric antigen receptors and uses thereofPRECIGEN INC·Filed 2022·Granted May 14, 2024·0 cites·81 claims
- 2175US11976134B2MUC16 specific chimeric antigen receptors and uses thereofPRECIGEN INC·Filed 2022·Granted May 7, 2024·0 cites·70 claims
- 2275US2024000973A1Frataxin expression constructsPRECIGEN INC·Filed 2023·Application pending·0 cites
- 2374US2025325665A1Fusion constructs and methods of using thereofPRECIGEN INC·Filed 2024·Application pending·0 cites
- 2473US12018310B2Methods and microorganisms for making 1,4-butanediol and derivatives thereof from C1 carbonsPRECIGEN INC·Filed 2021·Granted Jun 25, 2024·0 cites·20 claims
- 2573US2023414661A1Polypeptide compositions comprising spacersPRECIGEN INC·Filed 2023·Application pending·0 cites
- 2671US12180517B2Expression of novel cell tagsPRECIGEN INC·Filed 2021·Granted Dec 31, 2024·0 cites·32 claims
- 2770US2024148908A1Compositions and methods for expression of multiple biologically active polypeptides from a single vector for treatment of cardiac conditions and other pathologiesPRECIGEN INC·Filed 2023·Application pending·0 cites
- 2869US2026098063A1Human papillomavirus vaccines and uses of the samePRECIGEN INC·Filed 2025·Application pending·0 cites
- 2968US12194094B2Fusion constructs and methods of using thereofPRECIGEN INC·Filed 2021·Granted Jan 14, 2025·0 cites·15 claims
- 3067US11998618B2Frataxin expression constructsPRECIGEN INC·Filed 2020·Granted Jun 4, 2024·0 cites·21 claims
- 3167US11608362B2Hepatitis B vaccines and uses of the samePRECIGEN INC·Filed 2019·Granted Mar 21, 2023·0 cites·16 claims
- 3266US2024141045A1Fusion constructs and methods of using thereofPRECIGEN INC·Filed 2022·Application pending·0 cites
- 3366US2024398926A1Novel adenovirus vaccine therapy for the treatment of recurrent respiratory papillomatosisPRECIGEN INC·Filed 2024·Application pending·0 cites
- 3465US2025388905A1POLYCISTRONIC miRNA CONSTRUCTS FOR IMMUNE CHECKPOINT INHIBITIONPRECIGEN INC·Filed 2023·Application pending·0 cites
- 3564US12404306B2Human papillomavirus vaccines and uses of the samePRECIGEN INC·Filed 2019·Granted Sep 2, 2025·0 cites·12 claims
- 3664US11421235B2Methods and microorganisms for the fermentation of methane to multi-carbon compoundsPRECIGEN INC·Filed 2018·Granted Aug 23, 2022·0 cites·11 claims
- 3763US2022072159A1Compositions and methods for expression of multiple biologically active polypeptides from a single vector for treatment of cardiac conditions and other pathologiesPRECIGEN INC·Filed 2021·Application pending·0 cites
- 3862US12275772B2ROR-1 specific chimeric antigen receptors and uses thereofPRECIGEN INC·Filed 2021·Granted Apr 15, 2025·0 cites·58 claims
- 3962US2024390475A1Human papillomavirus vaccines and uses of the samePRECIGEN INC·Filed 2024·Application pending·0 cites
- 4061US11154622B2Compositions and methods for expression of multiple biologically active polypeptides from a single vector for treatment of cardiac conditions and other pathologiesPRECIGEN INC·Filed 2018·Granted Oct 26, 2021·0 cites·14 claims
- 4161US2025223320A1Hepatitis b vaccines and uses of the samePRECIGEN INC·Filed 2025·Application pending·0 cites
- 4260US2026035432A1Ror-1 specific chimeric antigen receptors and uses thereofPRECIGEN INC·Filed 2025·Application pending·0 cites
- 4356US12570945B2Electroporation apparatus and methodPRECIGEN INC·Filed 2020·Granted Mar 10, 2026·0 cites·26 claims
- 4456US2024173396A1Human Papilloma Virus Vaccines and Uses of the Same for HPV Associated DiseasesPRECIGEN INC·Filed 2021·Application pending·0 cites
- 4555US2022220187A1Chimeric receptor therapyPRECIGEN INC·Filed 2022·Application pending·0 cites
- 4651US2022282282A1Buffer solutions for electroporationPRECIGEN INC·Filed 2022·Application pending·0 cites
- 4740US2021395773A1In vivo controlled combination therapy for treatment of cancerPRECIGEN INC·Filed 2019·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →